Synthesis of Recommendations From 25 Countries and 31 Oncology Societies: How to Navigate Through Covid-19 Labyrinth
| Autor: | Konstantinos Kamposioras, Davide Mauri, Konstantinos Papadimitriou, Alan Anthoney, Nadia Hindi, Branka Petricevic, Mario Dambrosio, Antonis Valachis, Pantelis Kountourakis, Jindrich Kopecky, Cvetka Grašič Kuhar, Lazar Popovic, Nataliya P. Chilingirova, George Zarkavelis, Ramon Andrade de Mello, Natalija Dedić Plavetić, Christos Christopoulos, Bianca Mostert, John R. Goffin, Dimitiros Tzachanis, Haytham Hamed Saraireh, Fei Ma, Ida Pavese, Maria Tolia |
|---|---|
| Přispěvatelé: | [Kamposioras,K] Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom. [Mauri,D, Zarkavelis,G] Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece. [Papadimitriou,K] Early Clinical Trials Unit, Antwerp University Hospital, Antwerp, Belgium. [Anthoney,A] Leeds Institute of Medical Research at St James' Hospital, University of Leeds, Leeds, United Kingdom. [Hindi,N] Department of Medical Oncology, University Hospital Virgen del Rocío, Sevilla, Spain. [Hindi,N] TERABIS Group, IBiS (Instituto de Biomedicina de Sevilla)/HUVR/CSIC/Universidad de Sevilla), Sevilla, Spain. [Petricevic,B] Medizinische Abteilung, Zentrum für Onkologie und Hämatologie mit Ambulanz und alliativstation Wilhelminenspital, Vienna, Austria. [Dambrosio,M] Department of Clinical Oncology, Clinica San Carlo, Milan, Italy. [Valachis,A] Department of Oncology, Faculty of Medicine & Health, Örebro University, Örebro, Sweden. [Kountourakis,P] Medical Oncology Department, Bank of Cyprus Oncology Centre, Nicosia, Cyprus. [Kopecky,J] Department of Clinical Oncology, University Hospital, Charles University-Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czechia. [Kuhar,CG] Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. [Popovic,L] Oncology Institute of Vojvodina, University of Novi Sad, Novi Sad, Serbia. [Chilingirova,NP] University Specialized Hospital for Active Treatment in Oncology, Medical Oncology Clinic, Sofia, Bulgaria. [Chilingirova,NP] Medical University Pleven, Pleven, Bulgaria. [de Mello,RA] Escola Paulista de Medicina, Federal University of São Paulo, São Paulo, Brazil. [de Mello,RA] Department of Biomedical Sciences and Medicine, University of Algarve, Faro, Portugal. [Plavetić,ND] University Hospital Centre, Zagreb Department of Oncology, School of Medicine, University of Zagreb, Zagreb, Croatia. [Christopoulos,C] Service de Radiothérapie Oncologique, Groupe Hospitalier Intercommunal Le Raincy-Montfermeil, Montfermeil, France. [Mostert,B] Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, Netherlands. [Goffin,JR] Department of Oncology, McMaster University Juravinski Cancer Centre, Hamilton, ON, Canada. [Tzachanis,D] Department of Medicine, University of California San Diego School of Medicine, La Jolla, CA, United States. [Saraireh,HH] Radiation Oncology Department, Jordanian Royal Medical Services, Amman, Jordan. [Ma,F] Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. [Pavese,I] Service d'Oncologie, GHT Grand Paris Nord-Est, Montfermeil, France. [Tolia,M] Department of Radiotherapy, School of Medicine, University of Crete, Heraklion, Greece., Medical Oncology |
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
Oncology
Cancer Research Service delivery framework Review Recommendations Disciplines and Occupations::Health Occupations::Medicine::Internal Medicine::Medical Oncology [Medical Subject Headings] 0302 clinical medicine Sociedades médicas Epidemiology Pandemic Medicine 030212 general & internal medicine Directrices para la planificación en salud Cancer COVID-19 oncology guidelines Instituciones oncológicas Chemicals and Drugs::Biological Factors::Antigens::Vaccines Synthetic [Medical Subject Headings] Diseases::Neoplasms [Medical Subject Headings] lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens Health Care::Health Services Administration::Organization and Administration::Decision Making Organizational [Medical Subject Headings] Health Care::Health Care Economics and Organizations::Health Planning::Health Planning Guidelines [Medical Subject Headings] Infectious Diseases Internacionalidad 030220 oncology & carcinogenesis international International Covid-19 medicine.medical_specialty Health Care::Environment and Public Health::Public Health::Epidemiologic Measurements::Risk Assessment [Medical Subject Headings] Coronavirus disease 2019 (COVID-19) Infecciones por coronavirus Oncology and Carcinogenesis Phenomena and Processes::Physiological Phenomena::Physiological Processes::Adaptation Physiological [Medical Subject Headings] Patient assessment lcsh:RC254-282 03 medical and health sciences societies Online search Internal medicine Effective treatment business.industry Prevention Health Care::Environment and Public Health::Public Health::Disease Outbreaks::Epidemics::Pandemics [Medical Subject Headings] Health Care::Health Care Economics and Organizations::Organizations::Societies::Societies Medical [Medical Subject Headings] Diseases::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections [Medical Subject Headings] Good Health and Well Being Infectious disease (medical specialty) recommendations Human medicine business Societies |
| Zdroj: | Frontiers in oncology Digital.CSIC. Repositorio Institucional del CSIC instname Frontiers in Oncology Frontiers in Oncology, 10:575148. Frontiers Media S.A. Repositório Científico de Acesso Aberto de Portugal Repositório Científico de Acesso Aberto de Portugal (RCAAP) instacron:RCAAP Frontiers in Oncology, Vol 10 (2020) |
| ISSN: | 2234-943X |
| Popis: | Introduction: Pandemic COVID-19 is an unexpected challenge for the oncological community, indicating potential detrimental effects on cancer patients. Our aim was to summarize the converging key points providing a general guidance in order to support decision making, pertaining to the oncologic care in the middle of a global outbreak. Methods: We did an international online search in twenty five countries that have managed a surge in cancer patient numbers. We collected the recommendations from thirty one medical oncology societies. Results: By synthesizing guidelines for a) oncology service delivery adjustments, b) general and specific treatment adaptations, and c) discrepancies from guidelines comparison, we present a clinical synopsis with the forty more crucial statements. A Covid-19 risk stratification base was also created in order to obtain a quick, objective patient assessment and a risk-benefit evaluation on a case-by-case basis. Conclusions: In an attempt to face these complex needs and due to limited understanding of COVID-19, a variability of recommendations based on general epidemiological and infectious disease principles rather than definite cancer-related evidence has evolved. Additionally, the absence of an effective treatment or vaccine requires the development of cancer management guidance, capitalizing on comprehensive COVID-19 oncology experience globally. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|